|
AHCYL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.4535928844216E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.61612994892857E-14 |
| Normal-vs-Stage2 |
6.64029999875027E-08 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.349800E-02 |
| Stage1-vs-Stage3 |
1.352320E-02 |
| Stage1-vs-Stage4 |
4.39770000000284E-05 |
| Stage2-vs-Stage3 |
1.138120E-03 |
| Stage2-vs-Stage4 |
3.95290000000381E-05 |
| Stage3-vs-Stage4 |
1.187560E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6278089987054E-12 |
| Normal-vs-AfricanAmerican |
5.90019999524571E-09 |
| Normal-vs-Asian |
7.57727214306669E-13 |
| Caucasian-vs-AfricanAmerican |
8.502100E-02 |
| Caucasian-vs-Asian |
3.543600E-01 |
| AfricanAmerican-vs-Asian |
3.779400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63102864547682E-12 |
| Normal-vs-Female |
1.66144875635155E-12 |
| Male-vs-Female |
3.080800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.72875080706581E-14 |
| Normal-vs-Age(41-60Yrs) |
2.74225087082414E-14 |
| Normal-vs-Age(61-80Yrs) |
3.88578058618805E-15 |
| Normal-vs-Age(81-100Yrs) |
5.80040000000004E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.178200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.200800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.177600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.979600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.415600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.553600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.25590005062293E-09 |
| Classical-VS-Follicular |
1.783500E-04 |
| Classical-VS-Other |
1.353600E-01 |
| Classical-VS-Normal |
1.66888725061654E-12 |
| Tall-VS-Follicular |
2.42694753183059E-13 |
| Tall-VS-Other |
4.449900E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.036170E-03 |
| Follicular-VS-Normal |
2.81229994847365E-09 |
| Other-VS-Normal |
2.14920303776012E-11 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.512745649914E-13 |
| Normal-vs-N1 |
3.33066907387547E-16 |
| N0-vs-N1 |
7.599200E-03 |
|
|
